Page last updated: 2024-09-05

anidulafungin and Liver Dysfunction

anidulafungin has been researched along with Liver Dysfunction in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Canbay, AE; Glöckner, A	1
Busuttil, RW; Limaye, AP; Meneses, K; Morris, MI; Pelletier, S; Safdar, N; Singh, N; Winston, DJ	1
Ruiz Camps, I; Vázquez López, L	1
Raasch, RH	1

Reviews

3 review(s) available for anidulafungin and Liver Dysfunction

Article	Year
[Liver dysfunctions in intensive care patients--consequences for the treatment of invasive Candida infections]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2015, Volume: 110, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Echinocandins; Humans; Inactivation, Metabolic; Intensive Care Units; Liver; Liver Diseases; Liver Function Tests; Treatment Outcome	2015
[Potential of anidulafungin in hematological patients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Azoles; Candidiasis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echinocandins; Fungemia; Hematologic Diseases; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Kidney Diseases; Liver Diseases; Mice; Neutropenia; Risk Factors	2008
Anidulafungin: review of a new echinocandin antifungal agent. Expert review of anti-infective therapy, 2004, Volume: 2, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Biotransformation; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Echinocandins; Fungi; Humans; Intestinal Absorption; Kidney Diseases; Liver Diseases; Mycoses; Peptides, Cyclic; Tissue Distribution	2004

Trials

1 trial(s) available for anidulafungin and Liver Dysfunction

Article	Year
Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:12 Topics: Adolescent; Adult; Aged; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Double-Blind Method; Echinocandins; Female; Fluconazole; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Incidence; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Risk Factors; Survival Rate; Transplant Recipients; United States; Young Adult	2014

Article

Year

Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:12

Topics: Adolescent; Adult; Aged; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Double-Blind Method; Echinocandins; Female; Fluconazole; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Incidence; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Risk Factors; Survival Rate; Transplant Recipients; United States; Young Adult

2014